🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

109 notícias encontradas para "identified"
Identification of new molecular markers for multiple myeloma paves path for more precise t
Researchers at Cima and Clinica Universidad de Navarra have identified new molecular mechanisms underlying multiple myeloma. This type of hematologic cancer, which affects the bone marrow, is characterized by its resistance to treatment, leading to relapses in patients. The resea
Inhaled analgesia is as effective as morphine for early pain relief, study shows
Treating pain while in the field can be very demanding. Researchers have finally identified an effective alternative for providing pain relief during the earliest phase of prehospital care, when establishing intravenous access can be difficult. The study is published in The Lance
Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.
Two prostate cancer mutations reveal opposite responses to ferroptosis therapy
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guid
New tumor map identifies high-risk B-cell lymphoma standard therapy may miss
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particula
New adenomyosis atlas reveals lesion-specific signals that may spare healthy uterine tissu
Researchers at the University of Liverpool have identified distinctive biological characteristics within adenomyosis lesions that could help pave the way for more targeted, less invasive treatments. The findings from a team based in Professor Dharani Hapangama's gynecology resear
PET scans reveal stage-linked tau signal in Huntington's disease brains
A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the stage of Huntington's disease. This discovery opens the doo
Study reveals a distinct subtype of eosinophilic esophagitis
Study reveals a distinct subtype of eosinophilic esophagitis
Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE)—a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with food passing properly. They found that 25% of children w
Researchers discover treatable cause of severe anemia associated with a cancer therapy
Researchers discover treatable cause of severe anemia associated with a cancer therapy
Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest iss
Researchers discover molecular 'switch' that simultaneously manages touch and pain
Researchers discover molecular 'switch' that simultaneously manages touch and pain
A research team led by Prof. Hyosang Lee of the Department of Brain Sciences at DGIST has identified TWIK-1, a type of potassium channel expressed in the spinal cord and peripheral sensory neurons of the somatosensory system, as a key molecular regulator of touch sensation and ch
Natural regulator may slow several cancers by shutting down fibroblasts, study finds
An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University of Cantabria) and CIC bioGUNE, member of BRTA, has identified a novel molecular mechanism that helps limit the progression of several types of cancer.
Mutations let JC polyomavirus evade antibodies, offering clues for vaccines and treatments
In people with severely compromised immune systems, JC polyomavirus can trigger an untreatable, often fatal brain disease. An international research team has identified how virus mutations can strategically interfere with how human antibodies recognize the virus, allowing it to e